CXT vs EW · P/E 19, rev $1.49B vs P/E 47, rev $1.39B
Crane NXT Co (CXT) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Crane NXT Co (CXT) is a specialty industrial machinery company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported CXT revenue for 2024-12-31 was $1.49B. Net income was $184.1M. Revenue was up 6.9% from 2023-12-31 to 2024-12-31. CXT currently screens at market cap $3.14B and trailing P/E 18.8.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
CXT currently screens at market cap $3.14B and trailing P/E 18.8. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the CXT and EW stock pages for the full models.
Not investment advice.